Celvivo ApS
Private limited companyCVR 35671099Odense SØActive
Celvivo ApS is a private limited company, based in Odense SØ, active in research and experimental development on natural sciences and engineering, founded in 2014. Equity was negative at the end of 2025 (−DKK 54.4m). The company made a loss in both 2024 and 2025, most recently DKK 45.6m. Operations are spread over 3 production units in 3 towns.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 638% (2024 → 2025), to −DKK 7.9m.
- The loss grew: from DKK 20.9m to DKK 45.6m (2024 → 2025).
Employees
- 1 more employees than a year earlier: 19 (07/2026) against 18 (07/2025).
Management and owners, last 24 months
- New in management: Tonni Bülow-Nielsen (board member, 03/12/2025), Lene Ploug Bülow (board member, 03/12/2025) and Patrik Olof Dahlén (chair of the board, 03/12/2025) (+7).
- Stepped down: Peter Willems-Alnøe (ceo, 09/08/2026), Lars Nørgaard (board member, 03/12/2025) and Søren Baisner Alnøe (board member, 03/12/2025) (+2).
- New owners registered: Fey Holding ApS (13/04/2025), Krystof Holding ApS (13/04/2025) and Danmarks Eksport- og Investeringsfond (07/07/2026) (+6).
- No longer registered as owner: EnViAc P/S (12/04/2025), Fey Holding ApS (12/04/2025) and T&w Holding A/S (12/04/2025) (+5).
Registrations, last 24 months
- 30/07/2026: Share capital changed from 92,840 DKK to 119,003 DKK
- 24/11/2025: Share capital changed from 80,382 DKK to 92,840 DKK
- 13/04/2025: Share capital changed from 65,027 DKK to 80,382 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | −2,544 | −1,040 | −2,493 | −1,489 | 1,463 | −7,875 | −638.4% |
| Operating profit (EBIT) | −4,578 | −5,944 | −19,042 | −21,450 | −17,332 | −28,801 | −66.2% |
| Profit before tax | −4,792 | −7,196 | −21,927 | −26,047 | −26,419 | −35,898 | −35.9% |
| Net profit | −3,602 | −4,727 | −16,077 | −20,274 | −20,899 | −45,568 | −118% |
| Total assets | 17,005 | 31,204 | 38,617 | 41,732 | 44,651 | 28,243 | −36.7% |
| Equity | −1,133 | −5,475 | −21,543 | −18,863 | −39,712 | −54,426 | −37.1% |
| Liabilities | 16,884 | 35,367 | 60,160 | 60,595 | 84,363 | 82,669 | −2% |
| Cash and cash equivalents | 1,653 | 178 | 22 | 24 | 45 | 48 | +8.3% |
| Average number of employees | 5 | 9 | 13 | 16 | 14 | 15 | +7.1% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 54.4m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/10/2024 – 30/09/2025 | 27/03/2026 | The company | PDF not statedXBRL |
| 2024 | 01/10/2023 – 30/09/2024 | 31/03/2025 | The company | PDFXBRL |
| 2023 | 01/10/2022 – 30/09/2023 | 07/02/2024 | The company | PDFXBRL |
| 2022 | 01/10/2021 – 30/09/2022 | 01/02/2023 | The company | PDFXBRL |
| 2021 | 01/10/2020 – 30/09/2021 | 08/02/2022 | The company | PDFXBRL |
| 2020 | 01/10/2019 – 30/09/2020 | 30/11/2020 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,609of 69,742 Better than 0% | No. 69,906of 69,964 Better than 0% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 300of 323 Better than 7% | No. 326of 329 Better than 1% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,478of 33,588 Better than 0% | No. 33,621of 33,687 Better than 0% |
| All companies of type ApS66,508 companies in the comparison | No. 66,260of 66,379 Better than 0% | No. 66,438of 66,505 Better than 0% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Celvivo ApS−DKK 7.9m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Celvivo ApS−DKK 45.6m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Celvivo ApS−DKK 54.4m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Celvivo ApS19
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Fey Holding ApS5%
- Krystof Holding ApS5%
- Danmarks Eksport- og Investeringsfond20%
- Voma Holding A/S5%
- T&w Holding A/S20%
- EnViAc P/S25%
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Søren Baisner Alnøe | Director | 08/03/2023 |
| Jacob Lundgreen Philipsen | CEO | 15/08/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Tonni Bülow-Nielsen | Board member | 03/12/2025 |
| Lene Ploug Bülow | Board member | 03/12/2025 |
| Patrik Olof Dahlén | Chair of the board | 03/12/2025 |
| Dorthe Mikkelsen | Board member | 03/12/2025 |
| Søren Baisner Alnøe | Board member | 30/07/2026 |
- Founders
- Fey Holding ApS
Former management (7)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Stephen John Fey | Director | 01/03/2014 | 02/09/2019 |
| Peter Willems-Alnøe | Director | 02/09/2019 | 07/03/2023 |
| Peter Willems-Alnøe | CEO | 08/03/2023 | 09/08/2026 |
| Lars Nørgaard | Board member | 13/04/2025 | 03/12/2025 |
| Søren Baisner Alnøe | Board member | 13/04/2025 | 03/12/2025 |
| Tonni Bülow-Nielsen | Chair of the board | 13/04/2025 | 02/12/2025 |
| Krzysztof Wrzesinski | Board member | 03/12/2025 | 30/07/2026 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør eller af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Address and production units
3 active production unitsØrbækvej 264
5220 Odense SØ
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Celvivo ApS | Ørbækvej 264, 5220 Odense SØ | 11 | 1025748812 |
| Celvivo ApS - Værløse | Ny Vestergårdsvej 25, 2, 3500 Værløse | 7 | 1026200578 |
| Celvivo ApS - Odder | Vitavej 71, 8300 Odder | 1 | 1027217849 |
Purpose
Selskabets formål er at drive virksomhed med bioteknologi og hermed forbundet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
77 registered events202613 changesmanagement 4 · capital 1 · ownership 7 · accounts 1
- ManagementJacob Lundgreen Philipsen appointed ceo
- ManagementPeter Willems-Alnøe stepped down as ceo
- CapitalShare capital changed from 92,840 DKK to 119,003 DKK
- ManagementSøren Baisner Alnøe appointed board member
- ManagementKrzysztof Wrzesinski stepped down as board member
- OwnershipEnViAc P/S registered as owner (25%)
- OwnershipT&W HOLDING A/S registered as owner (20%)
- OwnershipVOMA HOLDING A/S registered as owner (5%)
- OwnershipT&W HOLDING A/S is no longer registered as owner
- OwnershipEnViAc P/S is no longer registered as owner
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (20%)
- OwnershipDanmarks Eksport- og Investeringsfond is no longer registered as owner
- AccountsAnnual report for 2025 published
202525 changesmanagement 11 · capital 2 · ownership 10 · accounts 1 · industry 1
- ManagementPatrik Olof Dahlén appointed chair of the board
- ManagementDorthe Mikkelsen appointed board member
- ManagementKrzysztof Wrzesinski appointed board member
- ManagementTonni Bülow-Nielsen appointed board member
- ManagementLene Ploug Bülow appointed board member
- ManagementSøren Baisner Alnøe stepped down as board member
- ManagementLars Nørgaard stepped down as board member
- ManagementTonni Bülow-Nielsen stepped down as chair of the board
- CapitalShare capital changed from 80,382 DKK to 92,840 DKK
- CapitalShare capital changed from 65,027 DKK to 80,382 DKK
- ManagementSøren Baisner Alnøe appointed board member
- ManagementTonni Bülow-Nielsen appointed chair of the board
- ManagementLars Nørgaard appointed board member
- OwnershipT&W HOLDING A/S registered as owner (15%)
- OwnershipEnViAc P/S registered as owner (33.33%)
- OwnershipKRYSTOF HOLDING ApS registered as owner (5%)
- OwnershipFEY HOLDING ApS registered as owner (5%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (20%)
- OwnershipJochumsen Invest ApS is no longer registered as owner
- OwnershipT&W HOLDING A/S is no longer registered as owner
- OwnershipKRYSTOF HOLDING ApS is no longer registered as owner
- OwnershipFEY HOLDING ApS is no longer registered as owner
- OwnershipEnViAc P/S is no longer registered as owner
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
202311 changesownership 6 · capital 1 · management 3 · accounts 1
- OwnershipJochumsen Invest ApS registered as owner (5%)
- CapitalShare capital changed from 53,846 DKK to 65,027 DKK
- ManagementSøren Baisner Alnøe appointed director
- ManagementPeter Willems-Alnøe appointed ceo
- OwnershipT&W HOLDING A/S registered as owner (10%)
- OwnershipKRYSTOF HOLDING ApS registered as owner (10%)
- OwnershipPWA Holding 2019 ApS is no longer registered as owner
- ManagementPeter Willems-Alnøe stepped down as director
- OwnershipKRYSTOF HOLDING ApS is no longer registered as owner
- OwnershipT&W HOLDING A/S is no longer registered as owner
- AccountsAnnual report for 2022 published
20223 changesaddress 2 · accounts 1
- AddressMoved to Ørbækvej 264, 5220 Odense SØ
- AddressMoved to Middelfartvej 469, Lille Ubberud, 5491 Blommenslyst
- AccountsAnnual report for 2021 published
20213 changesownership 3
- OwnershipCELVIVO HOLDING IVS is no longer registered as owner
- OwnershipKRYSTOF HOLDING ApS registered as owner (15%)
- OwnershipFEY HOLDING ApS registered as owner (10%)
20206 changesaccounts 1 · capital 1 · ownership 4
- AccountsAnnual report for 2020 published
- CapitalShare capital changed from 50,000 DKK to 53,846 DKK
- OwnershipT&W HOLDING A/S registered as owner (5%)
- OwnershipPWA Holding 2019 ApS registered as owner (5%)
- OwnershipCELVIVO HOLDING IVS registered as owner (25%)
- OwnershipCELVIVO HOLDING IVS is no longer registered as owner
20197 changesname 1 · capital 1 · management 2 · ownership 3
- NameName changed from CELVIVO IVS to CELVIVO ApS
- CapitalShare capital changed from 10 DKK to 50,000 DKK
- ManagementPeter Willems-Alnøe appointed director
- ManagementStephen John Fey stepped down as director
- OwnershipCELVIVO HOLDING IVS registered as owner (33.33%)
- OwnershipEnViAc P/S registered as owner (50%)
- OwnershipCELVIVO HOLDING IVS is no longer registered as owner
20181 changeaddress 1
- AddressMoved to Middelfartvej 469, Lille Ubberud, 5491 Blommenslyst
20171 changeaddress 1
- AddressMoved to Middelfartvej 469, Lille Ubberud, 5491 Blommenslyst
20151 changeindustry 1
- IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20145 changesindustry 1 · ownership 1 · status 1 · management 1 · founded 1
- IndustryIndustry changed to Engroshandel med computere, ydre enheder og software (465100)
- OwnershipCELVIVO HOLDING IVS registered as owner (100%)
- StatusStatus changed to active
- ManagementStephen John Fey appointed director
- FoundedRegistered as CELVIVO IVS
Related companies
Same industry in Odense
- Evosep ApS73 employees
- OnRobot A/S41 employees
- Alphalyse A/S41 employees
- Pentabase A/S39 employees
- QNTM Labs ApS37 employees
- IRD Fuel Cells A/S35 employees
Same people in management
- Falck Danmark A/Svia Dorthe Mikkelsen
- Leo Pharma A/Svia Patrik Olof Dahlén
- Minerva Imaging ApSvia Patrik Olof Dahlén
- Christensen Kjærulff Statsautoriseret Revisionsaktieselskabvia Lars Nørgaard
- SSI Diagnostica A/Svia Patrik Olof Dahlén
- Contura International A/Svia Patrik Olof Dahlén
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.